Abstract:Conventional Gastrointestinal (GI) cancer treatments are quite expensive and have major hazards. Nowadays, a different strategy places more emphasis on creating tiny biologically active peptides that do not cause severe poisoning. Anticancer peptides (ACPs) are found through experimental screening, which is time-dependent and frequently fraught with difficulties. Gastric ACPs are emerging as a promising GI cancer treatment in the current day. It is crucial to identify novel gastric ACPs to have an improved knowledge of their functioning processes and treatment of gastric cancer. As a result of the post-genomic era's massive production of peptide sequences, rapid and effective ACPs using a computational method are essential. Several adaptive statistical techniques for distinguishing ACPs and non-ACPs have recently been developed. A variety of adapted statistically significant methods have been developed to differentiate between ACPs and non-ACPs. Despite significant progress, there is no specific model for the prediction of gastric ACPs because the specific model will predict a particular type of peptide more accurately and quickly. To overcome this, an initiative is taken for the creation of a reliable framework for the accurate identification of gastric ACPs. The current technique in particular contains four possible features along with one hybrid feature encoding mechanisms which are the target-class motif previously indicated by Amino Acid Composition, Dipeptide Composition, Tripeptide Composition (TPC), Pseudo Amino Acid Composition (PAAC), and their Hybrid. Machine Learning algorithms make high-performance and accurate prediction tools. Moreover, highly variable and ideal deep feature selection is done using an ANOVA-based F score for feature pruning. Experiments on a range of algorithms are carried out to identify the optimal operating strategy due to the diverse nature of learning. Following analysis of the empirical results, Naïve Bayes with TPC and Hybrid feature space outperforms other methods with 0.99 accuracy score on the testing dataset. To find the model generalization an external validation is carried out. In external datasets, the Extra Trees with PAAC features outperforms with the accuracy of 0.94. The comparison study shows that our suggested model will predict gastric ACPs more accurately and will be useful in drug development and gastric cancer. The predictive model can be freely accessed at https://github.com/humeraazad10/G-ACP.git.Communicated by Ramaswamy H. Sarma.

ACPScanner: Prediction of Anticancer Peptides by Integrated Machine Learning Methodologies

ACP-ML: A sequence-based method for anticancer peptide prediction

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

Large-scale comparative review and assessment of computational methods for anti-cancer peptide identification

Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

Effective identification and differential analysis of anticancer peptides

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

Anti-Cancer Peptides Identification and Activity Type Classification with Protein Sequence Pre-training

DRACP: a Novel Method for Identification of Anticancer Peptides.

mACPpred 2.0: Stacked Deep Learning for Anticancer Peptide Prediction with Integrated Spatial and Probabilistic Feature Representations

ACP-ESM2: The Prediction of Anticancer Peptides Based on Pre-trained Classifier

ACP-MLC: A two-level prediction engine for identification of anticancer peptides and multi-label classification of their functional types

ACP-check: An anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy

G-ACP: a machine learning approach to the prediction of therapeutic peptides for gastric cancer

To Assist Oncologists: An Efficient Machine Learning-Based Approach for Anti-Cancer Peptides Classification

MA‐PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism

ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation

ACP-CapsPred: an explainable computational framework for identification and functional prediction of anticancer peptides based on capsule network

LGBM-ACp: an ensemble model for anticancer peptide prediction and in silico screening with potential drug targets

Learning embedding features based on multisense-scaled attention architecture to improve the predictive performance of anticancer peptides